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INTRODUCTION:  Adrenocortical  carcinoma  (ACC)  is  a rare, but  highly  aggressive  type  of  tumor  with  an
annual  incidence  of  1–2  cases  per  million.  The  prognosis  is  poor  with  a  ﬁve-year  overall  survival  rate
of  ∼35%.  The  poor  prognosis  may  be  related  to the  advanced  stage  at which  the majority  of  ACCs  are
detected.  Complete  surgical  resection  remains  the  most  effective  treatment.
PRESENTATION  OF  THE  CASE:  A  51-year-old  female  patient  with  recent  onset  of dyspepsia,  ascites  and
peripheral  edema  was  referred  to  our  institution.  Computed  tomography  (CT)  and  Magnetic  Resonance
Imaging  (MRI) displayed  a 8  cm  Ø right  adrenal  mass.  Moreover  a tumor  thrombus  jutted  out  into  the  IVC,
left renal  vein  and  right  atrium.  An echocardiographic  evaluation  conﬁrmed  the  presence  of  the  tumor
thrombus  in  the  right  atrium.  The  patient  underwent  adrenalectomy  with  removal  of  its  intravascular
extension  with  the assistance  of cardiopulmonary  bypass  and  hypothermia.
DISCUSSION:  ACC  is  a rare malignancy  and  ACC with  tumor  thrombus  extension  is  a rare  presentation.
Patients  can  present  with  a  variety  of sign  and  symptoms,  depending  on  the  extent  of the tumor.  CT  scan
of  chest  and  abdomen  represents  the  gold  standard  in ACC  staging  while  magnetic  resonance  imaging
(MRI)  is  preferred  for  tumor  thrombus  characterization.  Complete  surgical  resection  with  a  negative
margin,  R0  resection,  is the  only  curative  option  for localized  disease.  Kidney  sparing  surgery  should  be
performed  when  possible.
CONCLUSION:  We  present  a rare case of Adrenocortical  carcinoma  with  tumor  thrombus  extending  into
the IVC  and  right  atrium.  Complete  resection  with  negative  margins  represents  the  best  therapeutic
chance  for  these  patients.
©  2015  Published  by Elsevier  Ltd.  on  behalf of Surgical  Associates  Ltd.  This  is an  open  access  article
he  CCunder  t
. Introduction
Adrenocortical carcinoma (ACC) is a rare, but highly aggressive
ype of tumor with an annual incidence of 1–2 cases per million
1–3]. Furthermore, a higher incidence of ACC has been reported in
emales. ACC behave a bimodal age distribution with two  peaks:
he ﬁrst, concerning children in the ﬁrst decade of life and the
ther regarding adults in the fourth to ﬁfth decades of life [4–6].
he prognosis is poor with a ﬁve-year overall survival rate of ∼35%.
hese low survival rates are in part related to the advanced stage
f ACCs detection. Complete surgical resection remains the most
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55, 00161 Rome, Italy.
E-mail address: annamaria.pronio@uniroma1.it (P. Annamaria).
ttp://dx.doi.org/10.1016/j.ijscr.2015.07.008
210-2612/© 2015 Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is a
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effective treatment and, along with an early staging, is among the
strongest predictors of overall survival. Up to 40% of adrenal tumors
are nonfunctional with late clinical manifestation during the course
of disease as a large mass causing early satiety, weight loss, or
abdominal pain [7]. The general surgical strategy for ACC is “en
bloc” resection, which often includes adjacent organs like kidney,
liver, pancreas, spleen, or bowel. Vena cava invasion, which qual-
iﬁes ACC as stage III disease, occurs most commonly with larger,
right-sides tumors. Infrequently, tumor thrombus can extend to
the renal vein, IVC and right atrium without invading the vascu-
lar endothelium. In these cases, extensive thrombectomy has been
advocated [8–9]. Herein, we report a rare case of ACC with inferior
vena cava and left renal vein involvement plus an additional right
atrium tumor thrombus extension in a female patient.
n open access article under the CC BY-NC-ND license (http://creativecommons.org/
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pFig. 1. Intraoperative Photographs. The IVC thrombus was  removed.
. Case report
A 51-year-old female patient with a family history of renal
ell carcinoma and retroperitoneal carcinoma was admitted to our
nstitution for a recent onset of dyspepsia, ascites and peripheral
dema. Laboratory values for plasma free metanephrines, aldos-
erone, potassium, and testosterone were all within normal range.
T scan and MRI  displayed a 8 cm Ø, right adrenal mass. A throm-
us extended into the IVC, left renal vein and right atrium. An
chocardiographic evaluation conﬁrmed the presence of the tumor
hrombus in the right atrium. Since the symptoms of the patient
orsened, the patient underwent urgent adrenalectomy with the
ssistance of cardiopulmonary bypass and hypothermia with full
emoval of its intravascular extension. The surgery required the
ollaboration of the general surgery team and the cardiothoracic
ne
The right atrium was opened and by direct visualization the
umor thrombus was completely removed by the atrium and by
he IVC (Figs. 1 and 2). The procedure was completed as usual
ithout complications, the postoperative course was  uneventful
nd the patient was discharged on postoperative day 10 with-
ut morbidity. The histopathology conﬁrmed the diagnosis of ACC
ith tumor thrombosis of IVC, left renal vein and right atrium. The
atient receive adjuvant mitotane therapy post operatively [13,14].
t the follow up time of 12 months, the patients remains free of
ocal/systemic recurrence.
. Discussion
ACC is a rare malignancy and ACC with tumor thrombus exten-
ion is a rare presentation of this pathology [1–3]. Patients can
resent with a variety of sign and symptoms, depending on the
xtent of the tumor. CT scan of the chest and the abdomen is rep-
esents to date, the gold standard for ACC staging. With regards to
he tumor thrombus, magnetic resonance imaging (MRI) represents
he better imaging modality in order to assess the extension and the
eatures of the thrombus. Complete surgical resection with a neg-
tive margin, R0 resection, is the only curative option for localized
isease [5]. The presence of a thrombus represent an additional
isk factor due to the supplementary complexity of the surgery.
ccordingly for tumors extending into the atrium, the institution
f a cardiopulmonary bypass as well as a cardiothoracic surgical
ssistance is mandatory [9–12]. Kidney sparing surgery should be
erformed when possible, reserving en bloc nephrectomy only in
he case of renal invasion. Yet, even with an R0 resection, 50–80% of
atients develop relapse and/or progression to metastatic disease.Fig. 2. Operative specimen: right adrenalectomy and tumor thrombus into the IVC,
right atrium and left renal vein was performed.
The role of surgery in patients with recurrent and metastatic dis-
ease remains controversial. A recent study by Erdogan et al., [15]
compared clinical outcomes in ACC relapsing patients who under-
went surgery with relapsing patients who  did not. They concluded
that progression-free survival was improved if the time elapsed
from the ﬁrst relapse was greater than 12 months and if patients
were suitable to undergo an R0 resection for their recurrence.
Although a debulking surgery, R2 resection, did not signiﬁcantly
improve progression-free survival. In this case, we accomplished a
R0 resection with an aggressive approach leading to a 12 month sur-
vival in absence of any signs of recurrence and with a good quality
of life. This conﬁrms that aggressive surgery should be considered
even in the setting of most advanced ACCs probably offering the
only chance of survival for this aggressive tumor.
4. Conclusion
Given the current and predicted impact of ACCs, although our
results have been obtained on a single patient and thus need to
be conﬁrmed on a wider sample, they prompt us to suggest a
meditation concerning the indication for an aggressive surgical
intervention. Since the long-term survival and remission are closely
related to the stage of the disease, complete resection with nega-
tive margins thus represents, to date, the best chance of cure for
the patient prolonging and improving their quality of life.Conﬂict of interest
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